Home > Balance Sheet > CIPLA

CIPLA
Total Non-Current Liabilities

    Back to Balance Sheet
CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results

CIPLA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹-31 Cr₹82 Cr₹184 Cr₹622 Cr₹1,660 Cr

What is the latest Total Non-Current Liabilities ratio of CIPLA ?

The latest Total Non-Current Liabilities ratio of CIPLA is ₹-31 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹-31 Cr
Mar2024₹82 Cr
Mar2023₹184 Cr
Mar2022₹622 Cr
Mar2021₹1,660 Cr

How is Total Non-Current Liabilities of CIPLA Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹-31 Cr
Negative
Mar2024 ₹82 Cr
-55.36
Mar2023 ₹184 Cr
-70.48
Mar2022 ₹622 Cr
-62.55
Mar2021 ₹1,660 Cr -

Compare Total Non-Current Liabilities of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹122,353.4 Cr -0.4% -3.4% 0.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,211.0 Cr 1.6% 6% -2% Stock Analytics
DIVIS LABORATORIES ₹171,898.0 Cr -0.7% -1.9% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,377.0 Cr -0.8% 7.4% 21.2% Stock Analytics
DR REDDYS LABORATORIES ₹103,789.0 Cr 1.2% 0.3% -1.5% Stock Analytics
MANKIND PHARMA ₹91,799.5 Cr -2.2% -9.4% -14.6% Stock Analytics


CIPLA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

-0.4%

-3.4%

0.8%

SENSEX

1%

2.5%

6.5%


You may also like the below Video Courses